Français
ItalianoBond Bristol Myers Squibb 3.25% ( US110122BB30 ) in USD
| Issuer | Bristol Myers Squibb | ||||||||||||||||||||||||||||||
| Market price |  98.93 % ▼ |
||||||||||||||||||||||||||||||
| Country |  United States
|
||||||||||||||||||||||||||||||
| ISIN code |
 US110122BB30 ( in USD )
|
||||||||||||||||||||||||||||||
| Interest rate | 3.25% per year ( payment 2 times a year) | ||||||||||||||||||||||||||||||
| Maturity | 02/27/2027 | ||||||||||||||||||||||||||||||
| Minimal amount | 2 000 USD | ||||||||||||||||||||||||||||||
| Total amount | 750 000 000 USD | ||||||||||||||||||||||||||||||
| Cusip | 110122BB3 | ||||||||||||||||||||||||||||||
| Standard & Poor's ( S&P ) rating | A ( Upper medium grade - Investment-grade ) | ||||||||||||||||||||||||||||||
| Moody's rating | A2 ( Upper medium grade - Investment-grade ) | ||||||||||||||||||||||||||||||
| Next Coupon | 02/27/2027 ( In 123 days ) | ||||||||||||||||||||||||||||||
| Detailed description |
Bristol Myers Squibb is a global biopharmaceutical company engaged in the research, development, and marketing of innovative medicines and biotherapeutics across various therapeutic areas, including oncology, cardiovascular disease, immunology, and fibrosis. Bristol Myers Squibb's US$750,000,000 3.25% bonds (CUSIP: 110122BB3, ISIN: US110122BB30) maturing February 27, 2027, currently trade at 97.64% of face value, with a minimum trading size of 2,000 bonds, paying semi-annual coupons, and are rated A by S&P and A2 by Moody's. |
||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||